Cargando…

(18)F-Fluoromisonidazole in tumor hypoxia imaging

Hypoxia is a common feature of solid tumors that is closely associated with radiotherapy and chemotherapy resistance, metastasis and tumors prognosis. Thus, it is important to assess hypoxia in tumors for estimating prognosis and selecting appropriate treatment procedures. (18)F-Fluoromisonidazole p...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zuoyu, Li, Xiao-Feng, Zou, Hongyan, Sun, Xilin, Shen, Baozhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706929/
https://www.ncbi.nlm.nih.gov/pubmed/29212283
http://dx.doi.org/10.18632/oncotarget.21662
_version_ 1783282318418378752
author Xu, Zuoyu
Li, Xiao-Feng
Zou, Hongyan
Sun, Xilin
Shen, Baozhong
author_facet Xu, Zuoyu
Li, Xiao-Feng
Zou, Hongyan
Sun, Xilin
Shen, Baozhong
author_sort Xu, Zuoyu
collection PubMed
description Hypoxia is a common feature of solid tumors that is closely associated with radiotherapy and chemotherapy resistance, metastasis and tumors prognosis. Thus, it is important to assess hypoxia in tumors for estimating prognosis and selecting appropriate treatment procedures. (18)F-Fluoromisonidazole positron emission tomography ((18)F-FMISO PET) has been widely used to visualize tumor hypoxia in a comprehensive and noninvasive way, both in the clinical and preclinical settings. Here we review the concept, mechanisms and detection methods of tumor hypoxia. Furthermore, we discuss the correlation between (18)F-FMISO PET and other detection methods, current applications of (18)F-FMISO PET and the development prospects of this imaging technology.
format Online
Article
Text
id pubmed-5706929
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-57069292017-12-05 (18)F-Fluoromisonidazole in tumor hypoxia imaging Xu, Zuoyu Li, Xiao-Feng Zou, Hongyan Sun, Xilin Shen, Baozhong Oncotarget Review Hypoxia is a common feature of solid tumors that is closely associated with radiotherapy and chemotherapy resistance, metastasis and tumors prognosis. Thus, it is important to assess hypoxia in tumors for estimating prognosis and selecting appropriate treatment procedures. (18)F-Fluoromisonidazole positron emission tomography ((18)F-FMISO PET) has been widely used to visualize tumor hypoxia in a comprehensive and noninvasive way, both in the clinical and preclinical settings. Here we review the concept, mechanisms and detection methods of tumor hypoxia. Furthermore, we discuss the correlation between (18)F-FMISO PET and other detection methods, current applications of (18)F-FMISO PET and the development prospects of this imaging technology. Impact Journals LLC 2017-10-07 /pmc/articles/PMC5706929/ /pubmed/29212283 http://dx.doi.org/10.18632/oncotarget.21662 Text en Copyright: © 2017 Xu et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Review
Xu, Zuoyu
Li, Xiao-Feng
Zou, Hongyan
Sun, Xilin
Shen, Baozhong
(18)F-Fluoromisonidazole in tumor hypoxia imaging
title (18)F-Fluoromisonidazole in tumor hypoxia imaging
title_full (18)F-Fluoromisonidazole in tumor hypoxia imaging
title_fullStr (18)F-Fluoromisonidazole in tumor hypoxia imaging
title_full_unstemmed (18)F-Fluoromisonidazole in tumor hypoxia imaging
title_short (18)F-Fluoromisonidazole in tumor hypoxia imaging
title_sort (18)f-fluoromisonidazole in tumor hypoxia imaging
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706929/
https://www.ncbi.nlm.nih.gov/pubmed/29212283
http://dx.doi.org/10.18632/oncotarget.21662
work_keys_str_mv AT xuzuoyu 18ffluoromisonidazoleintumorhypoxiaimaging
AT lixiaofeng 18ffluoromisonidazoleintumorhypoxiaimaging
AT zouhongyan 18ffluoromisonidazoleintumorhypoxiaimaging
AT sunxilin 18ffluoromisonidazoleintumorhypoxiaimaging
AT shenbaozhong 18ffluoromisonidazoleintumorhypoxiaimaging